Skip to content

Microvision MVIS Net Accretion Of Premium On Shortterm Investments

Net Accretion Of Premium On Shortterm Investments at other companies

Prime Medicine logo
Prime MedicinePRME
$431K+163%
Replimune Group logo
Replimune GroupREPL
$134K-92.5%
BlackSky Technology logo
BlackSky TechnologyBKSY
$552K+34.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.03M-55.2%
Calix logo
CalixCALX
$435K-62.0%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
-$338K

Other financials

Income statement

See full
Revenue$935.0K+58.7%
Gross profit$363.0K+831%
Operating income-$23.5M-67.3%
Net income-$25.3M+12.1%
EPS (diluted)-$0.08+33.3%

Balance sheet

See full
Cash & equivalents$21.5M-59.8%
Total debt$53.4M+10.0%
Total equity$39.5M-25.7%
Total assets$110.2M-5.6%

Cash flow

See full
Operating cash flow-$16.4M-16.6%
CapEx$143.0K+44.4%
Free cash flow-$16.6M-16.8%

Valuation

See full
Market cap$112.7M-58.9%
Enterprise value$144.63M-42.0%
P/S72.5×-33.6×

Profitability

See full
Gross margin-1,095%-1,159pp
Operating margin-5,938.4%-9,823pp
Net margin-5,887.8%-16,314pp
FCF margin-3,976.1%-9,170pp

Returns & leverage

See full
Return on equity-197.3%+168pp
Debt / equity1.4×+0.4×
Current ratio-0.8×

Where this comes from

Reported directly by Microvision in its filing.

Tagged under the XBRL concept MVIS:NetAccretionOfPremiumOnShorttermInvestments.

The official record: Microvision’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microvision's net accretion of premium on shortterm investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microvision's net accretion of premium on shortterm investments?
Microvision (MVIS) reported net accretion of premium on shortterm investments of -$81K in Q1 2026.
How has Microvision's net accretion of premium on shortterm investments changed year-over-year?
Microvision's net accretion of premium on shortterm investments increased by 31.4% year-over-year, from -$118K to -$81K.
What is the long-term trend for Microvision's net accretion of premium on shortterm investments?
Over 4 years (2021 to 2025), Microvision's net accretion of premium on shortterm investments has grown at a 57.7% compound annual growth rate (CAGR), from $86K to -$532K.
What does net accretion of premium on shortterm investments mean?
This represents the adjustment to the carrying value of short-term investments purchased at a premium, which is amortized over the life of the security. It reflects the non-cash impact of interest income recognition on the company's investment portfolio. This metric helps investors reconcile the difference between cash interest received and the effective interest income reported on the income statement.